Clinical trial
Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor…
NCT00058786 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00058786 |
|---|---|
| Title | Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells |
| Official title | Treatment of Chronic Lymphocytic B-Leukemia (B-CLL) With Human IL-2 Gene Modified and Human CD40 Ligand-Expressing Autologous Tumor Cells |
| Acronym | CLIMAT |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic B-Leukemia |
| Intervention type | Biological |
| Interventions | Injection of IL-2-secreting CD40L-expressing autologous B-CLL cells |
| Enrollment | 9 |
| Start date | Dec 1, 2002 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Apr 15, 2003 |
| Last update posted | May 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: